Vibe Bio (@vibebio) 's Twitter Profile
Vibe Bio

@vibebio

Every cure for every community. Join us.

ID: 1458222566162714626

linkhttps://linktr.ee/vibebio calendar_today09-11-2021 23:58:58

2,2K Tweet

3,3K Followers

432 Following

Vibe Bio (@vibebio) 's Twitter Profile Photo

🚨 Starting in 30 min! Biopharma BD teams are under pressure to source smarter & faster. Join our webinar to learn how AI helps: 🔍 Prioritize high-value assets ⚖️ Benchmark competitors ⚡️ Diligence faster—globally Don’t miss it! 👉hubs.ly/Q03pwNLh0 #biopharma #AI #BD

🚨 Starting in 30 min!
Biopharma BD teams are under pressure to source smarter & faster.
Join our webinar to learn how AI helps:
 🔍 Prioritize high-value assets
 ⚖️ Benchmark competitors
 ⚡️ Diligence faster—globally
Don’t miss it!
👉hubs.ly/Q03pwNLh0
 #biopharma #AI #BD
Biotechnology Innovation Organization (@iambiotech) 's Twitter Profile Photo

In just 2 weeks, over 20,000 #biotech innovators will arrive in Boston for #BIO2025, all with a shared goal - to collaborate, educate, and harness their ambition to turn bold ideas into needed breakthroughs. Learn more: convention.bio.org

Christian Angermayer (@c_angermayer) 's Twitter Profile Photo

It has always puzzled me how much big pharma has neglected mental health. Current treatments are suboptimal at best, while the number of people suffering from depression, anxiety, addiction, and other mental health challenges continues to rise. The modern world is clearly toxic

Vibe Bio (@vibebio) 's Twitter Profile Photo

Last week, the U.S. FDA dropped ELSA, a new generative AI tool for regulatory document review, a month early. → 1st use case: comparing/summarizing oncology drug submission docs → Faster reviews, cleaner communication, major efficiency wins Read more: fiercebiotech.com/cro/fda-launce…

Vibe Bio (@vibebio) 's Twitter Profile Photo

Better decisions = better drugs We recently had the opportunity to interview Jay Andersen, former Sr. Research Fellow at Eli Lilly and Company, about his experience in using statistics to drive better portfolio decisions. Read our full interview here: vibebio.com/blog/lessons-p…

Vibe Bio (@vibebio) 's Twitter Profile Photo

#BIO2025 is next week + we’ll be there. If you want to talk about: 🧠 Applying AI to BD & portfolio strategy 🚀 Accelerating diligence & pipeline prioritization 🔍 How VibeOne is transforming decision-making in drug development DM us or connect there. convention.bio.org

Biotech2050 Podcast (@biotech2050pod) 's Twitter Profile Photo

🎙️#Biotech2050 host Alok Tayi chats with Howard Fillit, MD & Mark Roithmayr of Alzheimer's Drug Discovery Foundation on how they’re reshaping Alzheimer’s R&D—from blood tests to biotech bets. Discover how mission meets innovation. 🎧 Listen now: on.soundcloud.com/6ghbo9RPn55ElT… #Alzheimers #DrugDiscovery #HealthcareFunding

🎙️#Biotech2050 host <a href="/aloktayi/">Alok Tayi</a> chats with <a href="/a_hfillit/">Howard Fillit, MD</a> &amp; <a href="/TheADDFCEO/">Mark Roithmayr</a> of <a href="/TheADDF/">Alzheimer's Drug Discovery Foundation</a> on how they’re reshaping Alzheimer’s R&amp;D—from blood tests to biotech bets. Discover how mission meets innovation.
🎧 Listen now: on.soundcloud.com/6ghbo9RPn55ElT…
#Alzheimers  #DrugDiscovery #HealthcareFunding
Vibe Bio (@vibebio) 's Twitter Profile Photo

#BIO2025 — Lots of great convos about drug development. Key themes we heard: 📊 BD teams need better precision & faster turnaround 🧠 Human expertise + AI is a winning combo 🗺️ AI can help explore adjacencies & new opportunities Want to learn more? 👉 vibebio.com

Vibe Bio (@vibebio) 's Twitter Profile Photo

Portfolio strategy in pharma isn’t just art—or science. It’s both. Read this post to learn 🎯 Why better prioritization matters now more than ever 🧠 The hidden cost of legacy decision-making ⚡ How AI changes the game 👉 vibebio.com/blog/navigatin… #Biotech #Pharma #AI

Vibe Bio (@vibebio) 's Twitter Profile Photo

Great discussions at #BIO2025 about AI & BD strategy. A few takeaways from our conversations at the event: 📈 BD teams want better decision support ⚡️ Speed to insight matters 🎯 The intersection of AI + human expertise is where the real edge is Learn more vibebio.com

Vibe Bio (@vibebio) 's Twitter Profile Photo

#Biopharma #BD teams are under more pressure than ever. There's: 💥 More data 📉 Shrinking #pipelines ⏱️ Less time to evaluate assets 🤖 Limited expert capacity And yet, the pressure to move fast (and be right) is only increasing. How can you do that? 🔗 hubs.ly/Q03zSjgs0

#Biopharma #BD teams are under more pressure than ever. There's: 
💥 More data
📉 Shrinking #pipelines
⏱️ Less time to evaluate assets
🤖 Limited expert capacity
And yet, the pressure to move fast (and be right) is only increasing. How can you do that?
🔗 hubs.ly/Q03zSjgs0